Mini review · 2015
Mini reviewPublished 30 May 2016
The Cell-Free Mitochondrial DNA: A Novel Biomarker of Cardiovascular Risk?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Circulating cell-free mitochondrial DNA could find in healthy subjects and patients with neoplasia, trauma, infections, stroke, autoimmune, metabolic and rheumatic diseases. The triggers of cell-free mitochondrial DNA secretion are various impacts, i.e. microbial antigen stimulation, inflammatory cytokine, active molecules. It is speculated that the cell-free mitochondrial DNA might be a critical activator of inflammation, coagulation and the innate immune system linking mitochondrial dysfunction, cell death and target organ injury. There is evidence regarding that the cell-free mitochondrial DNA levels may elevate in healthy individuals depending aging and in cancer and non-cancer subjects at risk of CV diseases, as well as in persons with established CH disease. The results of several studies have shown that elevated circulating cell-free mitochondrial DNA has associated with cardiovascular (CV) diseases, while diagnostic and predictive value of this biomarker in non-cancer individuals is not fully clear. The mini review is devoted the biological role, diagnostic and predictive value of cellfree mitochondrial DNA in patients at CV risk.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2016
High Positive Predictive Value (PPV) of Cell-Free DNA (cfDNA) Testing in a Clinical Study of 10,000 Consecutive Pregnancies
Brief report · 30 May 2022
Brief Report on Genomic Analysis Using Cell-free DNA in Mediastinal B-cell Lymphoma
Conference proceeding · 7 Dec 2021
Liquid Biopsy Monitoring Of Circulating Cell-Free Tumour DNA and Identification of Cancer Gene Variations for Precision Diagnostics
Conference abstract · 10 Jul 2017
Development of an automated system for the analysis of cell-free fetal DNA from maternal plasma for noninvasive pre-natal diagnostics
More from this journal
The newest in Translational Biomedicine.
Research article · 30 Dec 2024
An Examination of the Correlation between Advancements in TBI Research and the Long-Term Health Outcomes of High-Risk Populations: The Use of Biomarkers vs. Symptom Assessment
Perspective · 20 Dec 2024
Preclinical and Animal Studies in Translational Biomedicine: Bridging the Gap Between Bench and Bedside
Perspective · 20 Dec 2024
Regenerative Medicine in Translational Biomedicine
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalTranslational Biomedicine
- SubjectCardiology
- SubjectGenetics & Molecular Biology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Alexander E Berezin”

